Sort
50,496 grants matching “lung cancer”
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$446,575Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2022 · CA
Therapeutic and Diagnostic Factors as Related to Cancer Risk
$446,543Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
CAREER: Predicting and Mining Phenome-genome Association across Species
$446,508Rui Kuang · University Of Minnesota-Twin Cities · · FY2012 · CSE
Utilizing Interaction to Identify Novel Genetic Factors for Nicotine Dependence
$446,477Dana B Hancock · Research Triangle Institute · R01 · FY2013 · DA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$446,417Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2020 · CA
REU Site: MedIX: Medical Informatics Experiences in Undergraduate Research
$446,384Daniela S Raicu · Depaul University · · FY2017 · CSE
Counterirritation by Menthol: Molecular Targets and Role in Airway Disease
$446,381Sven-Eric Jordt · Yale University · R01 · FY2011 · HL
Young Smoker's Reactions to Genetic Risk for Lung Cancer
$446,380Isaac M Lipkus · Duke University · R01 · FY2010 · CA
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
$446,372Oleh Taratula · Oregon State University · R37 · FY2022 · CA
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
$446,372Oleh Taratula · Oregon State University · R37 · FY2021 · CA
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
$446,368Monte Meier Winslow · Stanford University · R01 · FY2022 · CA
Liver kinase B1 in angiogenesis
$446,284Ming-Hui Zou · Georgia State University · R01 · FY2019 · CA
Research Project 2: Arsenic as an Endocrine Disruptor
$446,273Joshua W Hamilton · Dartmouth College · P42 · FY2007 · ES
Benefits and Harms of Lung Cancer Screening in HIV Infection
$446,246Kristina Anne Crothers · University Of Washington · R01 · FY2015 · CA
Precision lung cancer therapy design through multiplexed adapter measurement
$446,226Aaron Samuel Meyer · University Of California Los Angeles · U01 · FY2017 · CA
A Randomized trial of early palliative care for newly diagnosed cancer patients
$446,184Jennifer Temel · Massachusetts General Hospital · R01 · FY2015 · NR
Clustered semi-competing risks analysis in quality of end-of-life care studies
$446,179Sebastien Haneuse · Harvard School Of Public Health · R01 · FY2016 · CA
Clustered semi-competing risks analysis in quality of end-of-life care studies
$446,179Sebastien Haneuse · Harvard School Of Public Health · R01 · FY2017 · CA
University of Maryland, Baltimore Biomarker Reference Laboratory
$446,149Sanford A Stass · University Of Maryland Baltimore · U24 · FY2019 · CA
DNA Analysis Facility
$446,135Benoit De Crombrugghe · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$446,134Ralph R Weichselbaum · University Of Chicago · R01 · FY2023 · CA
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross
$446,100Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2020 · CA
Tools for Managing and Disseminating Cardiac Electrophysiology Data
$446,077Raimond Lester Winslow · Johns Hopkins University · R01 · FY2014 · HL
Experimental Cancer Imaging Research Program (ECIRP)
$446,017John D Hazle · University Of Tx Md Anderson Can Ctr · U24 · FY2009 · CA
Analyses of the Molecular Functions for D-Cyclins
$445,988Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2012 · CA